Search Results - "Bojková, Denisa"
-
1
Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery
Published in Vaccines (Basel) (01-07-2024)“…We investigated the basic characteristics of a new murine cytomegalovirus (MCMV) vector platform. Using BAC technology, we engineered replication-competent…”
Get full text
Journal Article -
2
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
Published in Cell research (01-03-2022)Get full text
Journal Article -
3
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Published in Nature (London) (16-07-2020)“…A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes…”
Get full text
Journal Article -
4
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
Published in Molecular cell (01-10-2020)“…SARS-CoV-2 infections are rapidly spreading around the globe. The rapid development of therapies is of major importance. However, our lack of understanding of…”
Get full text
Journal Article -
5
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
Published in The New England journal of medicine (26-03-2020)“…A group of 126 German nationals was evacuated from Wuhan to Frankfurt after screening for symptoms of Covid-19 and was to undergo a 14-day quarantine and…”
Get full text
Journal Article -
6
Lack of antiviral activity of darunavir against SARS-CoV-2
Published in International journal of infectious diseases (01-08-2020)“…•Darunavir showed no in vitro antiviral activity against SARS-CoV-2 (EC50 > 100 μM).•Remdesivir demonstrated potent antiviral activity, confirming validity of…”
Get full text
Journal Article -
7
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
Published in Cardiovascular research (01-12-2020)“…Abstract Aims Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has emerged as a global pandemic…”
Get full text
Journal Article -
8
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
Published in Scientific data (26-02-2021)“…SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, in which acute respiratory infections are associated with high socio-economic burden…”
Get full text
Journal Article -
9
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
Published in Basic research in cardiology (05-07-2021)“…Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can…”
Get full text
Journal Article -
10
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Published in PloS one (16-07-2021)“…Of the 16 non-structural proteins (Nsps) encoded by SARS CoV-2, Nsp3 is the largest and plays important roles in the viral life cycle. Being a large,…”
Get full text
Journal Article -
11
Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
Published in International journal of molecular sciences (20-06-2020)“…The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread…”
Get full text
Journal Article -
12
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
Published in The Journal of biological chemistry (01-08-2021)“…Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific…”
Get full text
Journal Article -
13
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Published in Cell discovery (10-05-2022)Get full text
Journal Article -
14
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Published in Medical microbiology and immunology (01-08-2021)“…The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread…”
Get full text
Journal Article -
15
SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach
Published in International journal of infectious diseases (01-05-2022)“…•International travel enables the spread of SARS-CoV-2 and its viral variants•The antigen test showed a sensitivity of 100% with respect to in vitro…”
Get full text
Journal Article -
16
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
Published in Stem cell reports (09-03-2021)“…Previous studies reported on the safety and applicability of mesenchymal stem/stromal cells (MSCs) to ameliorate pulmonary inflammation in acute respiratory…”
Get full text
Journal Article -
17
Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection
Published in International journal of molecular sciences (19-01-2022)“…SARS-CoV-2 uses the human cell surface protein angiotensin converting enzyme 2 (ACE2) as the receptor by which it gains access into lung and other tissue…”
Get full text
Journal Article -
18
Aprotinin Inhibits SARS-CoV-2 Replication
Published in Cells (Basel, Switzerland) (30-10-2020)“…Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under…”
Get full text
Journal Article -
19
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING
Published in Cell death & disease (06-08-2022)“…Pattern recognition receptors (PRRs) and interferons (IFNs) serve as essential antiviral defense against SARS-CoV-2, the causative agent of the COVID-19…”
Get full text
Journal Article -
20
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Published in Metabolites (13-10-2021)“…SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of…”
Get full text
Journal Article